🇺🇸 FDA
Pipeline program

Dexmedetomidine

GZFPH-IRB-2013-086

Unknown small_molecule completed

Quick answer

Dexmedetomidine for Benign Neoplasm of Vocal Fold - Glottis is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Benign Neoplasm of Vocal Fold - Glottis
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials